Autologous BMMNCs Combined With Educational Intervention Versus Educational Intervention for ASD

  • End date
    Jun 30, 2023
  • participants needed
  • sponsor
    Vinmec Research Institute of Stem Cell and Gene Technology
Updated on 19 April 2022
Accepts healthy volunteers


The purpose of this study is to evaluate the safety and effectiveness of autologous bone marrow mononuclear cell infusion combined with educational intervention for children with autism spectrum disorder (ASD). Inclusion criteria includes: Male/Female patients diagnosed with Autism disorder based on DSM-V scale, patient is between from 3 to 7 years old, patient has a medium level to server level of autism (CARS score>=30 to <50), VARS-2 >=50, patient's parent or caregiver must have educational level of high school or above, patient's family has given consent to participate in the study. Exclusion criteria for treatment group includes: patient above 7 years of age and smaller than 3 year old, austistic patients having epilepsy, hydrocephalus with ventricular drain, allergy to anesthetic agents, severe health conditions such as cancer, failure of heart, lung, liver or kidney, active infections, children with birth defects of the spine.


A total of 54 patients with autism spectrum disorder (aged 3-7) will be recruited and divided into two groups: the control group (only intervention education) (n = 27) and the treatment group (bone marrow mononuclear cell transplantation combined intervention education (n =27). The bone marrow mononuclear cell will be applied for 27 patients in the treatment group infuse via the intrathecal administration. The primary outcome is measured by the number of AEs/SAEs during BMMNCs infusion. The secondary outcome was measured by clinical examinations were performed at baseline and then at 02, 06, and 12 months after the first infusion. Multiple tools were used to diagnose and determine the severity of ASD level, including DSM-5, CARS, the Vineland Adaptive Behavior Scales Second Edition (VABS-II), and the Clinical Global Impression (CGI). DSM-5, which was published in May 2013, provides new diagnostic criteria for ASD

Condition Autism Spectrum Disorder
Treatment Autologous BMMNCs transplantation and educational intervention
Clinical Study IdentifierNCT05307536
SponsorVinmec Research Institute of Stem Cell and Gene Technology
Last Modified on19 April 2022


Yes No Not Sure

Inclusion Criteria

Patient is between 3 to 7 years old
Male/Female patient diagnosed with Autism disorder according to the diagnostic criteria for Autism Spectrum Disorder in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
Patient has a medium level to serve level of autism (CARS score >=34 to 50)
Patient's parent or caregiver must have educational level of high school or above
Patient's family has given consent to participate in the study

Exclusion Criteria

Patient is above 7 years of age
Autistic patient having epilepsy
Patient with coagulation disorders
Hydrocephalus with ventricular drain
Allergy to anesthetic agnets
Sever health conditions such as cancer, failure of heart, lung, liver, or kidney
Active infections
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note